B. Stanek

发表

Sequential big endothelin plasma levels in heart transplant recipients during bridging therapy and after successful heart transplantation.

A. Zuckermann, J. Strametz-Juranek, R. Pacher, 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Delayed effects of one-year treatment with low-dose as compared with high-dose enalapril on morbidity and mortality of patients with severe heart failure

R. Berger, R. Pacher, M. Hülsmann, 1998 .

Neurohumoral and hemodynamic effects of the selective endothelin antagonist darusentan in advanced chronic heart failure.

R. Berger, R. Pacher, J. Bergler-Klein, 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.

K. Silberbauer, B. Stanek, H. Templ, 1982, British journal of clinical pharmacology.

Sudden Death and Staged Therapy for Hemodynamic Stabilization in Patients Enrolled in a Heart Transplantation Program

R. Berger, M. Hülsmann, B. Frey, 1995, Pacing and clinical electrophysiology : PACE.

Acute effects of alinidine on heart rate and blood pressure in healthy subjects and patients with hyperkinetic heart syndrome

G. Raberger, P. Placheta, B. Stanek, 2004, European Journal of Clinical Pharmacology.

Effect of captopril on renin and blood pressure in cirrhosis

K. Silberbauer, F. Renner, B. Stanek, 2004, European Journal of Clinical Pharmacology.

Increase in bicycloprostaglandin E2 metabolite in congestive heart failure in response to captopril

K. Silberbauer, C. Punzengruber, B. Stanek, 1989, Clinical cardiology.

Bicyclo-prostaglandin E2 metabolite in congestive heart failure and relation to vasoconstrictor neurohumoral principles.

H. Sinzinger, K. Silberbauer, C. Punzengruber, 1986, The American journal of cardiology.

Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition.

K. Silberbauer, B. Stanek, H. Templ, 1982, British journal of clinical pharmacology.

BNP Testing in Heart Failure - One Fits All?

B. Stanek, 2003 .

Association of NT-proBNP levels and physical fitness in long-term heart transplant recipients

A. Aliabadi, A. Zuckermann, R. Berger, 2007 .

The effect of single and repeated oral doses of isosorbide dinitrate on plasma renin activity and plasma catecholamine levels in conscious dogs

G. Raberger, P. Placheta, O. Kraupp, 1980, Basic Research in Cardiology.

Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression.

R. Berger, M. Huelsmann, R. Pacher, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Plasma concentrations of noradrenaline and adrenaline and plasma renin activity during extradural blockade in dogs.

M. Zimpfer, G. Raberger, B. Stanek, 1980, British journal of anaesthesia.

Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation period.

R. Berger, M. Huelsmann, R. Pacher, 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pharmacologic Bridging With Prostaglandin E1 Before Heart Transplantation - A New Chance for an Old Drug

B. Stanek, 2002 .

FAILING HEART-MEDICAL ASPECTS Experience with b-Blocker Therapy in Patients with Advanced Heart Failure Evaluated for HTx

R. Berger, R. Pacher, B. Frey, 2000 .

B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure

R. Berger, R. Pacher, M. Huelsman, 2002, Circulation.

Plasma catecholamines, plasma renin activity and haemodynamics during sodium nitroprusside-induced hypotension and additional beta-blockade with bunitrolol

M. Zimpfer, G. Raberger, S. Fitzal, 2004, European Journal of Clinical Pharmacology.

Cardiovascular effects of dihydroergotamine during epidural anaesthesia in dogs.

M. Zimpfer, G. Raberger, B. Stanek, 1981, Pharmacology.

Cardiovascular Effects of Dihydroergotamine in High Epidural Analgesia and Mild Acute Hypovolemia

M. Zimpfer, G. Raberger, S. Fitzal, 1980, Regional Anesthesia & Pain Medicine.

Effects of Endothelin A Receptor Blockade on Endothelial Function in Patients With Chronic Heart Failure

R. Berger, R. Pacher, M. Hülsmann, 2001, Circulation.

Acute and chronic effects of captopril on bicyclo-PGEm, the stable bicyclic end product of prostaglandin E2 in essential hypertension.

K. Silberbauer, B. Stanek, 1986, Nephron.

Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure.

S. Graf, R. Berger, R. Pacher, 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Optimising Management of Patients with Advanced Heart Failure

B. Stanek, B. Stanek, 2000, Drugs & aging.

Felodipine is more effective than hydrochlorothiazide when added to a beta-blocker in treating elderly hypertensive patients.

M. Weissel, B. Stanek, G. Flygt, 1990, Journal of cardiovascular pharmacology.

Effect of β1 blockade with atenolol on progression of heart failure in patients pretreated with high‐dose enalapril

R. Berger, R. Pacher, B. Sturm, 2000, European journal of heart failure.

Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experience

R. Pacher, B. Staněk, B. Stanek, 1999, European journal of heart failure.

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction.

E. Hartter, R. Berger, R. Pacher, 2001, Journal of the American College of Cardiology.

Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.

R. Pacher, B. Staněk, B. Frey, 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

B-type natriuretic peptides (BNP and PRO-BNP) predict longterm survival in patients with advanced heart failure treated with atenolol.

R. Berger, M. Huelsmann, R. Pacher, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure.

G. Maurer, E. Hartter, E. Ogris, 1996, Journal of the American College of Cardiology.

Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.

G. Laufer, R. Berger, R. Pacher, 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Angiogenesis stimulation in explanted hearts from patients pre-treated with intravenous prostaglandin E(1).

T. Thalhammer, G. Steiner, T. Wild, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Experience with beta-blocker therapy in patients with advanced heart failure evaluated for HTx.

R. Berger, R. Pacher, M. Hülsmann, 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Intravenous therapy for advanced heart failure.

R. Pacher, B. Staněk, B. Stanek, 2000, Current opinion in cardiology.

ACE inhibitor dosage at the time of listing predicts survival.

G. Kuchling, R. Berger, R. Pacher, 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.

E. Hartter, J. Vítovec, R. Pacher, 1999, Japanese heart journal.

Effects of continuous, long-term therapy with prostaglandin E1 preoperatively on outcome after heart transplantation.

G. Laufer, A. Zuckermann, R. Pacher, 1999, Transplantation proceedings.

Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables.

E. Ogris, G. Laufer, R. Berger, 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.

E. Hartter, E. Ogris, R. Berger, 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Effect of prostaglandin E1 infusion in severe chronic heart failure.

H. Sinzinger, R. Pacher, M. Hülsmann, 1997, Prostaglandins.

Acceptance of a pump-driven infusion therapy with prostaglandin E1 as a bridge to heart transplantation.

G. Laufer, E. Wolner, R. Pacher, 1996, Wiener klinische Wochenschrift.

Moderate-intensity exercise training with elements of step aerobics in patients with severe chronic heart failure.

R. Pacher, M. Quittan, G. Wiesinger, 1999, Archives of physical medicine and rehabilitation.

Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure.

G. Maurer, R. Berger, R. Pacher, 1998, Journal of the American College of Cardiology.